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Abstract
Mutations in the gap junction protein connexin47 (Cx47) are associated with lymphedema.
However, the role of Cx47 in lymphatic pathophysiology is unknown. We demonstrate that
Cx47 is expressed in lymphatic endothelial cells by whole-mount immunostaining and
qPCR. To determine if Cx47 plays a role in lymphatic vessel function we analysed Cx47-/-
mice. Cx47-deficiency did not affect lymphatic contractility (contractile amplitude or fre-
quency) or lymphatic morphology (vessel diameter or number of valves). Interstitial fluid
drainage or dendritic cell migration through lymphatic vessels was also not affected by
Cx47-deficiency. Cx47 is dispensable for long-chain fatty acid absorption from the gut
but rather promotes serum lipid handling as prolonged elevated triglyceride levels were
observed in Cx47-deficient mice after oral lipid tolerance tests. When crossed with Apolipo-
protein E-deficient (Apoe-/-) mice, LDL-cholesterol was decreased in young Cx47-/-Apoe-/-
adults as compared to Apoe-/- mice, which was inverted later in life. Finally, advanced ath-
erosclerotic plaques in thoracic-abdominal aortas of 15 months-old mice tended to be larger
in Cx47-/-Apoe-/- mice. These plaques contained fewer macrophages but similar amounts
of T lymphocytes, collagen and lipids than plaques of Apoe-/- mice. In conclusion, Cx47 is
expressed in lymphatic endothelium and seems modestly implicated in multiple aspects of
lymphatic pathophysiology.
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Introduction
Although the incidence of lymphedema is still on the rise, proper treatment for this painful
and crippling condition is unavailable. Lymphedema can be inherited or secondary, i.e. caused
by medical treatment or trauma. Importantly, it has recently been shown that mutations in
various genes, such as FOXC2, VEGFR3, SOX18, GATA2 and CCBE1, predispose to lymph-
edema, hinting to involvement of proteins encoded by these genes in this disease [1]. Recently,
the connexin protein family has been added to the repertoire of lymphedema-associated genes
[2–5].
Connexins are transmembrane proteins that are expressed throughout the body. These pro-
teins are inserted in cell membranes as hexamers (connexons) that can be composed of one or
several types of connexins. In specific pathological conditions, connexons can function as
hemi-channels allowing for diffusion of small soluble factors from the cytosol to the extracellu-
lar space or vice versa. More commonly, a connexon docks to a connexon expressed by an
adjacent cell thereby forming a gap junction channel allowing for cytoplasmic exchange of
ions and small metabolites between neighboring cells [6]. As such, gap junction channels are
critically involved in direct cell-cell communication and synchronization of tissue responses
[7, 8].
Several autosomal recessive mutations in GJC2 (which encodes connexin47 (CX47)), have
been associated with lymphedema [3–5]. These mutations result in amino acid changes in
various domains of the CX47 protein; i.e. H19P (N-terminus), S48L (first extracellular loop),
R125Q and G149S (intracellular loop), R260C (second extracellular loop) and P316L (C-termi-
nus). The functional consequences of these mutations on CX47 channels are largely unknown.
Like Cx37 and Cx43 [9, 10], Cx47 has been detected in subgroups of lymphatic endothelial
cells (LECs), particularly in lymphatic valves, of young mice [10, 11]. It is now well established
that both Cx37 and Cx43 play important roles during lymphatic valve development [9–11].
However, only sparse and fractional information about the expression and role of Cx47 in
adult lymphatic vessels exists [12, 13]. Hence, the current study addressed possible involve-
ment of Cx47 in lymphatic pathophysiology.
Results
Cx47 is expressed in LECs
Initially Cx47 expression was thought to be restricted to oligodendrocytes in the central ner-
vous system (CNS), where they contribute to myelination [14–16]. More recently, Cx47 has
also been detected in lymphatic valve LECs of young mice [10, 11, 13]. Here, we studied
expression of Cx47 in lymphatics of adult mice. Unfortunately, immunostainings with vari-
ous commercially available Cx47 antibodies resulted in non-specific staining; i.e. prominent
staining in tissues isolated from Cx47-deficient mice (data not shown). We therefore opted
to use alternative approaches to demonstrate Cx47 expression. First, we isolated mRNA
from different organs and assessed the presence of Gjc2 (the gene encoding Cx47) by quanti-
tative PCR (qPCR). As expected, Gjc2 was expressed in the brain from Cx47-expressing
(hereafter Cx47+/+) control mice whereas this was not the case for mRNA samples isolated
from the brain of mice in which eGFP was knocked-in into the Gjc2 locus (Cx47eGFP/eGFP;
hereafter Cx47-/-) (Fig 1A). We also detected higher levels of Gjc2 expression in mRNA sam-
ples isolated from the ear and mesentery of Cx47+/+ mice as compared to mRNA isolated
from Cx47-/- mice (Fig 1A). Moreover, this tended to be the case in mRNA isolated from the
gut as well (Fig 1A). In order to identify the particular cell type expressing Gjc2, we isolated
primary blood endothelial cells (BECs) and LECs from the gut and the lungs of wild-type
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(WT) mice. Initially, we confirmed the purity of these cell preparations by qPCR focusing on
genes specific for BECs or LECs. LECs but not BECs expressed high levels of lymphatic endo-
thelial cell specific Prox1 (Fig 1B). On the contrary, in agreement with previous findings [13]
BECs but not LECs expressed high levels of Flt1 (which encodes VEGFR1; Fig 1B). More-
over, LECs but not BECs from the gut and the lung express Gjc2 (Fig 1C). Finally, Gjc2 pro-
moter activity was assessed in 2 days-old Cx47eGFP/eGFP mice by whole-mount confocal
microscopy on lymphatic vessels in the hindlimb region using methods described previously
for proximal femoral veins [17]. These experiments showed heterogeneous eGFP expression
in PROX1/PECAM1 positive LECs in Cx47eGFP/eGFP but not in Cx47+/+ mice (Fig 1D). Thus,
Gjc2 expression was observed in LECs of young as well as adult mice and Cx47 may thus play
a role in lymphatic pathophysiology.
Fig 1. Cx47 is expressed by lymphatic endothelial cells. A) Expression of Gjc2 in total mRNA isolated
from the brain, ear, mesentery (Mes.) and gut from Cx47-/- (black bars) or Cx47+/+ mice (white bars). N = 3. B)
Expression of Prox1 (upper panels) or Flt1 (lower panels) in lymphatic endothelial cells (LECs; white bars) or
blood endothelial cells (BECs; black bars) isolated from the gut (left panels) or the lung (right panels) of wild-
type mice. C) Expression of Gjc2 in LECs (white bars) or BECs (black bars) isolated from the gut (left panel) or
lung (right panel) of wild-type mice. N = 6. D) Presence (asterisks) of eGFP in PROX1/PECAM1 positive
LECs of Cx47eGFP/eGFP but not Cx47+/+ mice. Scalebar equals 20 μm.
https://doi.org/10.1371/journal.pone.0181476.g001
Lymphatic Cx47
PLOS ONE | https://doi.org/10.1371/journal.pone.0181476 July 21, 2017 3 / 21
Cx47 does not alter lymphatic morphology
Deficiency for other connexins (e.g. Cx37 and Cx43 [9–11]) has been linked to changes in lym-
phatic morphology. To explore whether Cx47-deficiency would alter lymphatic morphology
we performed confocal microscopy on the dermis of ears isolated from Cx47-/-Prox1tg/+ or con-
trol (Cx47+/+Prox1tg/+) mice (Fig 2A) to quantify whether the number of lymphatic valves was
affected by Cx47-deficiency (Fig 2B). Moreover, we used intravital microscopy on lymphatic
collecting vessels of the same mice to quantify their diameter (Fig 2C). In line with an earlier
study [18], these experiments showed that, contrary to Cx37- and Cx43-deficiency [9, 10],
Cx47-deficiency does not affect the number of lymphatic valves (Fig 2D). In addition, they
also indicated that lymphatic diameter is not affected by Cx47-deficiency (Fig 2E).
Lymphatic Cx47 does not affect lymphatic contractility
Previous studies have shown that lymphangions in collecting lymphatic vessels function as
independent units; i.e. fluid flows in, this increases the intraluminal pressure resulting in the
depolarization of a group of ‘pace-maker’ cells thereby creating an action potential that tra-
verses the lymphangion and thus causes contraction and expulsion of the lymphatic fluid [19].
Interestingly, early studies have shown that synchronization of lymphatic tissue responses is
disrupted in presence of chemical gap junction channel blockers such as heptanol or oleic acid
[20, 21]. To investigate whether Cx47 is involved in coordinated contractility in lymphangions,
we studied the amplitude and frequency of spontaneous contractions of the lymphangions in
the lymphatic collecting vessel that drains the inguinal lymph node from Cx47-/-Prox1tg/+
Fig 2. Normal lymphatic vessel organization in Cx47-deficient mice. A) Schematic illustration showing
localization of mOrange2 positive lymphatic vessels in a Cx47+/+Prox1tg/+ mouse. As indicated (red boxes),
the number of lymphatic valves was quantified in three separate images covering > 75% of the inner ear
surface. Moreover, lymphatic diameter was quantified in the lymphatic vessel draining the inguinal lymph
node (green box). B) Representative image showing lymphatic valves (arrowheads) in the inner ear of a
Cx47+/+Prox1tg/+ mouse. C) Representative image showing the measurement of the lymphatic diameter in a
Cx47+/+Prox1tg/+ mouse at equidistance between two valves. D) Quantification of the number of lymphatic
valves in Cx47+/+Prox1tg/+ (white bar) and Cx47-/-Prox1tg/+ (black bar) mice. E) Quantification of the lymphatic
diameter in Cx47+/+Prox1tg/+ (white bar) and Cx47-/-Prox1tg/+ (black bar) mice. N = 7.
https://doi.org/10.1371/journal.pone.0181476.g002
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or Cx47+/+Prox1tg/+ mice using intravital microscopy and video analysis. In line with expecta-
tions [19, 22], we observed rhythmic contractions with a frequency of approximately 3.5 con-
tractions/minute (see S1 Movie for a typical example). This frequency was not affected by
Cx47-deficiency (Fig 3A). Moreover, even though prominent contractile amplitudes were
detected in lymphatic collecting vessels from Cx47+/+Prox1tg/+ mice, these were unaltered in
collecting vessels from Cx47-/-Prox1tg/+ mice (Fig 3B). Thus, Cx47-deficiency in LECs does not
directly affect the contractions of lymphatic vascular smooth muscle cells in Cx47-deficient
mice.
Lymphatic Cx47 does not contribute to drainage of lymphatic fluids
It has been shown that gap junctions are involved in contractile lymphangion responses that
regulate interstitial fluid drainage [20, 21]. In order to study tissue drainage, we quantified
spread of Evans Blue towards the blood after injection in the left food pad (Fig 4A and [23])
of Cx47-/- or Cx47+/+ mice. We clearly observed dermal spread of Evans Blue (Fig 4B) but
Cx47-deficiency did not alter the extent to which Evans Blue spread towards the blood 15 min-
utes after injection (Fig 4C).
Lymphatic Cx47 does not regulate lymphocyte trafficking
Lymphatic vessels are important regulators of immune responses; i.e. they form conduits by
which immune cells can travel from sites of inflammation towards lymph nodes. It should be
noted that immune cells within lymphatic vessels do not passively follow lymphatic flow.
Rather, both dendritic cells (DCs) and T cells closely interact with LECs when they enter into
lymphatic capillaries and then actively crawl from these capillaries into the downstream col-
lecting vessels [24, 25]. Furthermore, LECs can present antigens and shape peripheral lympho-
cyte responses [26]. Moreover, gap junctions are involved in DC-mediated T lymphocyte
activation [27]. Theoretically, Cx47 could play a role in any of these aspects regulating immu-
nity. Thus, we studied migration of DCs in Cx47-/- and Cx47+/+ mice using a model to induce
lymphocyte trafficking. In line with earlier findings [28], exposure of the skin to a 1:1 acetone-
butyl phthalate mixture resulted in enhanced DC migration towards draining lymph nodes.
However, the total cell number in draining lymph nodes was not affected by absence of Cx47
(Fig 5A) and, importantly, the amount of migratory DCs in draining lymph nodes was not
affected by Cx47-deficiency either (Fig 5B). Thus, Cx47 does not seem to modulate trafficking
of DCs through the lymphatic system.
Fig 3. Lymphatic contractility is not regulated by Cx47. A/B) Quantification of the frequency (A) and
amplitude (B) of lymphatic contractions in Cx47+/+Prox1tg/+ (white bars) and Cx47-/-Prox1tg/+ (black bars)
mice. N = 7/11.
https://doi.org/10.1371/journal.pone.0181476.g003
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Fig 4. Lymphatic Cx47 does not regulate tissue drainage. A) Scheme illustrating the experimental
procedure; mice received an Evans Blue injection in their footpad. Fifteen minutes after the injection, blood
was collected and Evans Blue was detected in the serum using fluorescence. B) Typical examples of the
spread of Evans Blue in the footpad of a Cx47+/+ mouse and examples of samples obtained from the serum of
Cx47+/+ or Cx47-/- mice. Initially (t = 0, t = 1; top images), the Evans Blue does not spread extensively (black
Lymphatic Cx47
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Cx47 affects serum lipid handling but not uptake of long-chain fatty acids
from the gut
Lacteals, a special type of lymphatic vessels present in the gut, are vital for uptake of long-chain
fatty acids from the intestine [29]. To investigate the role of Cx47 in lacteal function we per-
formed oral lipid tolerance tests using Cx47-/- and Cx47+/+ mice. As expected [29], we noticed
an increase in both free fatty acids (FFAs) and triglycerides in the serum of Cx47+/+ mice 1
hour after gavage with olive oil (Fig 6A and 6B). Moreover, the FFA and triglyceride serum lev-
els returned to basal values 3 hours after gavage (Fig 6A and 6B). As expected, exposure to
olive oil did not affect serum cholesterol, low-density lipoproteins (LDL) or high-density lipo-
proteins (HDL) 1 hour post-gavage (Fig 6C–6E), however, their values tended to be decreased,
or were significantly decreased 3 hours post-gavage. In Cx47-/- mice exposure to olive oil had
very similar effects: it resulted in a transient increase in FFA levels, and had no effect on cho-
lesterol, HDL or LDL or tended to decrease presence of these lipids in the serum (Fig 6A and
6C–6E). However, serum triglyceride levels in Cx47-/- mice remained increased until 3 hours
after gavage (Fig 6B) whereas at this time point they had returned to baseline in Cx47+/+ mice.
Thus, acute uptake of lipids from the intestine is not affected by Cx47-deficiency but serum
lipid handling might be subtly regulated by Cx47.
Cx47-deficiency affects serum lipid levels but not plaque size of chow-
fed Apoe-/- mice
There is increasing evidence for a role of lymphatics in atherosclerosis [30], a chronic inflam-
matory disease of the arterial wall in which serum lipids play a crucial role [31]. Since our
results suggest that lipid handling is affected by Cx47, we first studied serum lipid levels in ath-
erosclerosis-susceptible Cx47-/- Apoe-/- and Cx47+/+Apoe-/- mice fed a regular chow diet. We
initially compared serum lipid values in Cx47-/-Apoe-/- of young adult or old mice (4 or 15
months) to serum lipid values in age-matched Cx47+/+Apoe-/- mice. In 4 month-old Cx47-/-A-
poe-/- mice, we detected reduced levels of serum cholesterol, LDL and HDL as compared to
line) from the site of injection. However, 15 minutes later, the spread is more extensive (black line). Moreover,
15 minutes after injection (middle image), the Evans Blue has spread towards draining lymph nodes (arrow)
via afferent lymphatics (asterisk) and has advanced further via efferent lymphatics (arrowhead). Indeed, after
15 minutes (lower images) Evans Blue can readily be detected in the serum of Cx47-/- (left image) and Cx47+/
+ mice (right image). C) Quantification of the Evans Blue present in the serum of Cx47+/+ (white bar) or Cx47-/-
(black bar) mice 15 minutes after injection. N = 10/14.
https://doi.org/10.1371/journal.pone.0181476.g004
Fig 5. Cx47 does not modulate acute immune responses. A 1:1 mixture of acetone and dibutyl phthalate
was applied epicutaneously to Cx47+/+ or Cx47-/- mice. Twenty-four hours later, draining lymph nodes were
excised and analyzed by flow cytometry using antibodies targeting CD11c or MHCII. In this classical model,
Cx47-deficiency does neither affect A) the total amount of cells in inflammation draining lymph nodes nor B)
the amount of migratory DCs in Cx47+/+ (white bars) or Cx47-/- (black bars) mice. N = 6.
https://doi.org/10.1371/journal.pone.0181476.g005
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PLOS ONE | https://doi.org/10.1371/journal.pone.0181476 July 21, 2017 7 / 21
Cx47+/+Apoe-/- mice (Fig 7A–7C) whereas triglycerides and FFA were similar between geno-
types (Fig 7D and 7E). In 15 months-old mice, the situation was partly reversed; i.e. we
observed increased serum cholesterol and LDL levels in Cx47-/-Apoe-/- mice as compared to
Cx47+/+Apoe-/- mice (Fig 7A and 7B). In this age group serum HDL, triglycerides and FFA
were not affected by genotype (Fig 7C–7E). We next studied the spontaneous development
of advanced atherosclerosis in 15 months-old Cx47-/-Apoe-/- and Cx47+/+Apoe-/- mice.
Fig 6. Uptake of long-chain fatty acids is not altered by Cx47-deficiency. A-E) Quantification of FFA (A),
triglycerides (B), total cholesterol (C), LDL (D), or HDL (E) in serum of Cx47+/+ (white bars) or Cx47-/- (black
bars) mice at 0, 1 or 3 hours after oral gavage of olive oil (10 μl/gr bodyweight). Note that as expected, the
serum content of FFA and triglycerides significantly increases whereas the level of total cholesterol, LDL and
HDL is not affected by gavage. N = 6.
https://doi.org/10.1371/journal.pone.0181476.g006
Lymphatic Cx47
PLOS ONE | https://doi.org/10.1371/journal.pone.0181476 July 21, 2017 8 / 21
Surprisingly, we observed that plaque size in thoracic-abdominal aortas (Fig 8A) or aortic
roots (Fig 8B) was not affected by genotype despite altered serum lipid levels in Cx47-/-Apoe-/-
mice.
Cx47-deficiency does not directly affect the size of diet-induced
atherosclerotic plaques
Atherosclerotic plaque formation typically follows serum LDL-cholesterol values. Hence,
since LDL-cholesterol was decreased in young adult Cx47-/-Apoe-/- mice but increased in old
Cx47-/-Apoe-/- mice, we fed Cx47-/-Apoe-/- and Cx47+/+Apoe-/- mice from the age of 10-weeks a
high-cholesterol diet for 10 or 25 weeks. After either 10 or 25 weeks of high-cholesterol diet,
serum total cholesterol, LDL and HDL were elevated by 2-3-fold but similar for either geno-
type (Fig 9A–9C). Similarly, triglyceride and FFA levels were also not affected by the genotype
(Fig 9D and 9E). As lymphatic vessels mostly arise in the vicinity of plaque hypoxia due to
local VEGF-C/D release in advanced atherosclerotic plaques [30, 32, 33], we then studied
Fig 7. Serum lipid levels are affected by Cx47-deficiency. Serum lipids were determined in non-fasted 4 or
15 months-old Cx47+/+Apoe-/- (white bars) or Cx47-/- Apoe-/- (black bars) mice. A) Total cholesterol levels are
decreased in 4 month-old Cx47-/- mice but increased in 15 month-old Cx47-/-Apoe-/- mice. B) LDL serum
levels are decreased in 4 month-old Cx47-/-Apoe-/- mice but increased in 15 month-old Cx47-/-Apoe-/- mice. C)
HDL levels are decreased in in 4 month-old Cx47-/-Apoe-/- mice. D-E) Cx47-deficiency does not alter serum
free triglyceride (D) or fatty acid (FFA, E) in any experimental group. N = 6/11.
https://doi.org/10.1371/journal.pone.0181476.g007
Lymphatic Cx47
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plaque size in thoracic-abdominal aortas and aortic roots of Cx47-/-Apoe-/- and Cx47+/+Apoe-/-
mice that had received cholesterol-rich diet for 25 weeks. These studies showed a trend
towards increased plaque size in thoracic-abdominal aortas of Cx47-/-Apoe-/- mice (Fig 10A,
p = 0.07). Conversely, no genotype-induced differences were observed however in plaque size
in aortic roots (Fig 10B).
Plaque composition is subtly regulated by Cx47
Atherosclerotic plaque size is not per se the most important determinant of disease severity in
atherosclerosis. Indeed, patients presenting stable plaques (containing a low amount of macro-
phages, many smooth muscle cells and displaying a large lipid core and a relatively thick
fibrous cap) are at lower risk for plaque rupture and thrombus formation as compared to
patients with an unstable plaque [34, 35]. This is especially of interest in the context of lym-
phatic vessels in the vicinity of the plaque since these are important regulators of reverse cho-
lesterol transport and immune cell migration [36–38]. Thus, we studied plaque composition in
i) 15 month-old Cx47-/-Apoe-/- mice in which serum LDL-cholesterol levels were increased
compared with Cx47+/+Apoe-/- controls and ii) in Cx47-/-Apoe-/- mice that had received choles-
terol-rich diet for 25 weeks and had elevated LDL-cholesterol levels in both genotypes. We
focused on main determinants of plaque stability being: i) macrophages, ii) T lymphocytes, iii)
collagen and iv) lipid content. In spontaneously developed advanced plaques in 15 months-old
mice, we did not observe genotype-dependent differences regarding plaque macrophage, T
lymphocyte, collagen or lipid content (Fig 11A and 11B). However, in diet-induced atheroscle-
rotic lesions in Cx47-/-Apoe-/- mice macrophage content was significantly reduced although
collagen, lipid or T lymphocyte contents were not affected by genotype (Fig 11C and 11D).
Discussion
LECs express Cx47 ([10–13] and this study) and GJC2 mutations are associated with lymph-
edema (3, 4). However, only sparse and fractional information about a role for Cx47 in lym-
phatic physiology exists. Hence, in the current study we thoroughly assessed involvement of
Fig 8. Spontaneous atherosclerotic plaque formation is not affected by Cx47-deficiency. A/B)
Quantification of plaque size in thoracic-abdominal aortas (A) or aortic roots (B) as observed in 15 month-old
Cx47+/+ Apoe-/- (white bars) and Cx47-/-Apoe-/- (black bars) mice. C/D) Representative images of C) en face
thoracic-abdominal aortas or D) aortic roots stained with Sudan IV. N = 11.
https://doi.org/10.1371/journal.pone.0181476.g008
Lymphatic Cx47
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Cx47 in lymphatic physiology. Specifically, we observed expression of Cx47 in LECs but not
BECs from different mouse organs. Thereafter, we used genetic approaches to address the in
vivo function of Cx47 regarding i) lymphatic morphology, ii) lymphatic pumping, iii) drainage
of interstitial fluids, iv) acute immune responses in terms of migration of DCs towards antigen
draining lymph nodes, v) uptake of long-chain fatty acids from the gut, vi) effects on serum
lipid values during chow or high-cholesterol diet and vii) chronic immune responses in terms
of modulation of atherosclerotic plaque size but also plaque content.
Our main findings are that i) Cx47 is involved in the reversal of acute increases in serum tri-
glycerides, ii) serum lipid levels of mice on chow but not high-cholesterol diet are affected by
Cx47 and iii) Cx47-deficiency tends to increase plaque size but decreases macrophage content
of diet-induced atherosclerotic plaques.
Lymphatics, most notably lacteals, are critically involved in uptake of lipids from the intes-
tine. Indeed, disrupted lacteal biology leads to disturbed serum lipid levels [29]. Moreover,
lymphatic connexins, such as Cx37, have been shown to affect lacteal development [39] but
whether this is also the case for Cx47 is unknown. Furthermore, whether Cx47 in LECs
Fig 9. After high-cholesterol diet, serum lipid levels are unaffected by Cx47-deficiency. Serum lipids
were determined in non-fasted Cx47+/+Apoe-/- (white bars) and Cx47-/-Apoe-/- (black bars) mice, which
received high cholesterol diet for 10 or 25 weeks. In this experimental setting, serum cholesterol (A), LDL (B),
HDL (C), triglycerides (D) or FFA levels are unaffected by genotype. N = 9/11.
https://doi.org/10.1371/journal.pone.0181476.g009
Lymphatic Cx47
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Fig 10. After high-cholesterol diet, atherosclerotic plaque formation tends to be enhanced by
Cx47-deficiency. A/B) Quantification of plaque size in thoracic-abdominal aortas (A) or aortic roots (B) as
observed in Cx47+/+Apoe-/- (white bars) or Cx47-/-Apoe-/- (black bars) mice. C/D) Representative images of C)
en face thoracic-abdominal aortas or D) aortic roots stained with Sudan IV. N = 9/11.
https://doi.org/10.1371/journal.pone.0181476.g010
Fig 11. Cx47 subtly regulates atherosclerotic plaque composition. Plaque composition was determined
in the aortic roots of 15 month-old Cx47+/+Apoe-/- (white bars) and Cx47-/-Apoe-/- (black bars) mice (upper
panels) or Cx47+/+Apoe-/- (white bars) and Cx47-/-Apoe-/- (black bars) mice that had received high-cholesterol
diet for 25 weeks (lower panels). A/B) In 15 month-old mice no differences between the genotypes were
observed. C) In plaques from Cx47-/-Apoe-/- (black bars) mice exposed to high cholesterol diet macrophage
content was reduced whereas collagen and lipid content was unaffected by genotype. D) After a high-
cholesterol diet T lymphocyte content was not affected by genotype. N = 9/11.
https://doi.org/10.1371/journal.pone.0181476.g011
Lymphatic Cx47
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regulates lipid uptake is currently unclear. We showed that the uptake of FFA or triglycerides
from the intestine is not affected by Cx47-deficiency (Fig 6). However, the data also show that
dampening of the triglyceride peak, which occurred 1 hour after olive oil gavage, tended to be
delayed in Cx47-/- mice. These observations suggest that Cx47 may be fine-tuning the process-
ing of serum lipids. This hypothesis was supported by the fact that in Apoe-/- mice fed chow
diet Cx47-deficiency resulted in enhanced or reduced serum lipid levels, depending on the age
of the mice (Fig 7). This effect of Cx47 was no longer observed in Apoe-/- mice fed a high-cho-
lesterol diet, which is most likely due to a saturation of the lipid handling system (Fig 9). The
mechanism by which Cx47 fine-tunes the handling of serum lipids is at present still not clear,
but it should be noted that deletion or reduction of other connexins in the blood vessel or lym-
phatic endothelium (Cx37, Cx40 or Cx43) does not alter serum lipid levels [40–42]. Hence, it
is unlikely that interactions between these connexins and Cx47 play a role. Moreover, Cx47
expression has not been reported in the main lipid handling organs such as adipose tissue,
liver and skeletal muscle. Thus, a direct effect of Cx47-deficiency on lipid handling mediated
by these organs seems also unlikely. In contrast, Cx47 is highly expressed in oligodendrocytes
within the CNS [43, 44]. Importantly, it has been shown that the CNS can contribute to the
regulation of serum lipids by controlling e.g. hepatic activity [45–47]. However, whether-or-
not Cx47 in the CNS contributes to regulation of serum lipid metabolism is beyond the scope
of this study.
Atherosclerosis is a chronic inflammatory disease of large- to medium-sized arteries. The
disease is characterized by plaques that develop in the intimal space in arterial segments that
are exposed to low and/or oscillatory shear stress [35, 48]. Advanced plaques contain lipids
(most notably oxidized LDL), immune cells (most notably macrophages), extracellular matrix
components (collagen) and newly developed (lymphatic) vessels. Classically, plaque immune
cells have gained attention because of their role in maintenance of a persistent pro-inflamma-
tory loop. Extracellular matrix components on the other hand have been studied since these
structures provide much needed stability to plaques. Finally, newly formed lymphatic vessels
have recently been suggested to play an important role in atherosclerotic plaques as well [30,
32, 33]; i.e. they provide pathways by which immune cells (e.g. macrophages) can egress from
the plaques thereby facilitating reverse cholesterol transport [36] and are thus thought to
be anti-atherogenic. In addition, the lymphatic system can also affect atherogenesis by modu-
lating serum lipid values which generally directly translate into enhanced, or reduced, athero-
sclerotic plaque burden [31]. Hence, one would expect enhanced atherogenesis in mice
characterized by increased serum total cholesterol or LDL levels (e.g. in 15 months-old
Cx47-deficient mice) and decreased atherogenesis in mice with decreased serum levels of these
lipids (such as the 4 months-old Cx47-deficient mice). However, we found a tendency to
increased plaque development in thoracic-abdominal aortas of Cx47-deficient mice that had
received high-cholesterol diet for 25 weeks (Fig 10A). This difference in plaque development
was not induced by serum lipid levels, because those were similar in Cx47-expressing and
Cx47-deficient mice on a high-cholesterol diet both after 10 weeks and 25 weeks of diet. Thus,
lymphatic Cx47 could be reducing plaque size in thoracic-abdominal aortas of Cx47+/+Apoe-/-
mice by enhancing egress of immune cells. Intraplaque neovessels are generally thought to
arise from preexisting adventitial structures [30, 32, 33]. Hence, one would expect that a possi-
ble anti-atherogenic role of Cx47 would not be found in atherosclerotic plaques at locations
characterized by low levels of adventitial lymphatics such as aortic roots. Our observations
with respect to plaque development in the aortic roots of Cx47-/-Apoe-/- and Cx47+/+Apoe-/-
mice confirm this hypothesis (Fig 10B).
The amount of plaque macrophages was slightly reduced in Cx47-/-Apoe-/- mice that had
received high-cholesterol diet for 25 weeks (Fig 11C), suggesting enhanced egression of
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macrophages from atherosclerotic plaques in Cx47-deficient mice. Egression of immune cells
from atherosclerotic plaques might be affected by changes in lymphatic contractility, lym-
phatic-mediated interstitial tissue drainage and/or lymphatic-dependent immune cell migra-
tion. However, our findings suggest that Cx47-deficiency is not affecting any of these
processes directly (Figs 3–5). Finally, macrophages do not express Cx47. Hence, a direct effect
of Cx47-deficiency on processes such as macrophage proliferation/apoptosis/necrosis seems
unlikely as well.
Altogether, our data show that Cx47-deficient mice do not display an overt lymphatic phe-
notype. This is surprising since mutations in GJC2 have been linked to primary and secondary
lymphedema in patients [3, 4]. The reason(s) for the apparent discrepancy between the find-
ings in patients and our findings in mice are not entirely clear. However, it should be kept in
mind that several connexins (most notably, Cx37, Cx43 and Cx47 [9–11]) are co-expressed in
lymphatic endothelium. A first explanation may be that the level of endogenous Cx37/Cx43
expression by itself is sufficient to maintain adequate connexin function in absence of Cx47.
Secondly, knockout mice, or even mouse models with the same causative genetic mutations,
do often not fully recapitulate human disease or sometimes fail to show any phenotypic alter-
ation, suggesting the existence of compensatory mechanisms [49]. Thus, a compensatory up-
regulation of Cx43 for example might have counterbalanced for the loss of Cx47 in our mouse
models. This would by itself not be entirely surprising since compensatory mechanisms in
global (connexin) gene knockouts have been observed before [50]. One should however keep
in mind that functional replacement of one connexin gene with another in mice has demon-
strated that cellular homeostasis does not only depend on the presence of intercellular commu-
nication through gap junction channels but also requires the correct type of connexin in the
target cell [51] or even the correct type of connexin in adjacent cells. Indeed, Cx47 phosphory-
lation and stability in oligodendrocytes has been shown to critically depend on Cx43 expres-
sion in astrocytes, suggesting that there may be an intricate interplay between these two
connexins [52]. Finally, one should keep in mind that different connexin isoforms (i.e. Cx47,
Cx37, Cx43) may assemble in various combinations into heteromeric connexons (hemi-chan-
nels) and that differently assembled connexons can dock into heterotypic gap junction chan-
nels [53–55]. Consequently, mutations in connexin genes can give rise to mutant forms of the
proteins that can have dominant negative effects on other connexins within the same hemi-
channel or gap junction channel [3, 56]. For example, the Cx47-R260C mutation located
within the SRPTEK motif in the second extracellular loop may have such dominant negative
effects. This motif is important for connexon docking and a target for mimetic peptides that
inhibit gap junctional communication [57–59]. Thus, lymphedema-associated Cx47 mutations
in patients may not result in a loss-of-function of the Cx47 protein but may rather result in a
dominant negative effect on Cx43, another connexin expressed in LECs, thereby resulting in
altered function of heteromeric/heterotypic gap junctions affecting lymphatic physiology.
Although knock-out technologies have taught us much on the in vivo physiological role of




Animal experimentation conformed to the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health and was approved by Swiss cantonal veteri-
nary authorities. Atherosclerosis-susceptible mice with deletion of Cx47, i.e. Cx47-/-Apoe-/-
mice, on a C57BL/6 background were generated by crossing Apoe-/- mice [60] and mice
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expressing eGFP controlled by the Cx47 promoter (Cx47eGFP/eGFP) [16]. In addition, Cx47-/-
and Cx47+/+ mice were crossed with Prox1tg/+ mice [61] to visualize lymphatic vasculature in
Cx47-expressing and Cx47-deficient mice. Genotypes of the different mice were verified by
PCR using previously described protocols [16, 61]. Mice were in conventional housing on a
12-hour night-day cycle and had free access to food (either high-cholesterol diet or chow
pellets).
Quantitative PCRs on organs
Mice were killed by cervical dislocation. Thereafter, organs were collected and snap frozen.
Subsequently, RNA was isolated and qPCRs were performed using primers (Thermo scien-
tific) as previously described [62].
Isolation of LECs and BECs
LECs and BECs were isolated using cell sorting as previously described [29]. Total RNA was
isolated using the QIAGEN RNeasy Plus Micro Kit. Reverse transcription was performed
using Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics). Alternatively,
mRNA was amplified using Ovation Pico WTA System V2 (NuGEN). qPCRs were performed
using a StepOnePlus apparatus (Applied Biosystems) using SYBR Fast PCR Master Mixes
(Kapa Biosystems). Analysis of gene expression was carried out using the comparative Ct
(ΔΔCt) method as described by the manufacturer. Sequences of PCR primers are provided in
S1 Table.
Visualization of eGFP in LECs
eGFP was visualized in LECs as described before [17]. In brief, mice were culled and perfused
with heparinised PBS via the aorta prior to fixation in 4% paraformaldehyde (PFA) followed
by blocking in 3% v/v donkey serum in 0.3% Triton-x100. Samples were further dissected
prior to incubation with primary antibodies, and washed prior to localization with fluoro-
phore-conjugated secondary antibodies. Samples were then further dissected and mounted in
Prolong Gold (Invitrogen). The lymphatics were visualized by confocal microscopy (Leica
SP5) to produce Z projections (NIH ImageJ) of median filtered (Leica LASAF/ImageJ) stacks.
The following antibodies were used: rabbit anti-Prox1 (11-002P, Angiobio), goat anti-GFP
(ab6658, Abcam, Biotinylated), rat anti-PECAM1 (BD clone MEC 13.3) and mouse anti-alpha
smooth muscle actin (clone 1A4 conjugated to Cy3, Sigma).
Quantification of the number of lymphatic valves, lymphatic diameter and
lymphatic contractility
Cx47-/-Prox1tg/+ or Cx47+/+Prox1tg/+ mice were sedated as previously described [29]. The diam-
eter of the lymphatic collecting vessel draining the inguinal lymph node was measured by
intravital microscopy using a Leica M205FA stereomicroscope and simultaneously video anal-
ysis was performed to quantify lymphatic contractility in terms of percentage of contraction
and contractile frequency. Thereafter, mice were killed by cervical dislocation and the ears of
the mice were isolated and processed. In brief, the ears were fixed overnight at 4˚C and subse-
quently washed with PBS. Then the inner and outer parts of the dermis of the ear were sepa-
rated using forceps. For the quantification of lymphatic valves, we focused on the inner part of
the dermis. After separation, the inner part of the dermis was mounted on a microscopy slide
within the wall of three Secure-Seal spacers (Molecular Probes) in order to maintain the three-
dimensional structure. Thereafter, lymphatic vessels were visualized using a LSM700 confocal
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microscope (Zeiss). Three separate recordings were obtained in order to capture >75% of the
total ear surface. Z-stacks covering the layer of tissue in which lymphatics are present were
obtained during these recordings in order to capture all the lymphatics. After imaging the Z-
stacks were converted to a single plain using Fiji using the Z Project plugin. The number of
lymphatic valves was thereafter counted manually by two observers who were unaware of the
genotype of the mice and was subsequently normalized for the area of the ear.
Quantification of interstitial fluid drainage
Drainage of interstitial fluids was quantified using Evans Blue injections in the footpad of
Cx47-/-Apoe-/- or Cx47+/+Apoe-/- mice as described previously [23]. In brief, mice were sedated
as described above. Once anesthetized, the mice were injected with 5 μl 5% Evans Blue (dis-
solved in PBS) using a micro syringe. Subsequently, 15 minutes after the initial injection,
blood was collected from the left ventricle and serum was obtained. The serum was then incu-
bated overnight with formamide (Sigma-Aldrich; 1:1 ratio) at 55˚C. Thereafter, presence of
Evans Blue in the serum was quantified using a SpectraMax Paradigm Multi-Mode Microplate
reader (Molecular Devices).
Quantification of long-chain fatty acid uptake
The uptake of long-chain fatty acids was quantified as previously described [29]. In brief,
Cx47-/-Apoe-/- and Cx47+/+Apoe-/- mice were subjected to an overnight fast and subsequently
received olive oil (Sigma-Aldrich; 10 μl/gr bodyweight) by oral gavage. Blood was obtained by
submandibular puncture and the amount of serum lipids was determined at t = 0, 1 and 3
hours after gavage using a Cobas C111 (Roche Diagnostics).
Quantification of serum lipids and isolation of tissues to study
atherogenesis
Cx47-/-Apoe-/- and Cx47+/+Apoe-/- mice were used. They either received a high cholesterol diet
(1.5%, 0% cholate; Research Diets) for 10 or 25 weeks starting from the age of 10 weeks or,
alternatively, were fed regular chow until an age of 4 or 15 months. At the experimental day,
the mice were sedated as described above and blood was collected from the left ventricle,
serum was isolated and serum lipids were determined using a Cobas C111 (Roche Diagnos-
tics). After collection of the blood, the aortas of the mice were perfused with 0.9% NaCl before
being separated in the thoracic-abdominal part, which was fixed overnight in 2% PFA, and the
aortic root, which was frozen in OCT compound.
Quantification of plaque size
The extent of atherosclerosis in the thoracic-abdominal aortas and the aortic roots was quanti-
fied according to standard protocols [41, 63]. In brief, the thoracic-abdominal were stained
with Sudan IV and subsequently opened longitudinally and the extent of staining was assessed
using Fiji software. Plaque size in the aortic roots (in μm2) was also determined using Fiji soft-
ware in six 7-μm sections at 50 μm distension.
Plaque content quantification
7-μm sections from the aortic roots were immunolabeled with antibodies against CD68 (AbD
Serotec) or CD3 (DakoCytomation). Collagens were stained with Picrosirius Red and lipids
were stained using Sudan IV. Macrophage, collagen and lipid content were quantified by
dividing the CD68, Picrosirius Red or Sudan IV positive area by the total plaque area using
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Image J. The amount of plaque T lymphocytes was quantified by manual counting by two
observers who were unaware of the genotype of the mice.
Quantification of in vivo DC migration
Cx47-/-Apoe-/- and Cx47+/+Apoe-/- mice were used and dendritic cells migration was induced as
described previously [28]. Briefly, a 1:1 mixture of acetone and dibutyl phthalate was applied
epicutaneously. Twenty-four hours later, draining lymph nodes were excised and analyzed by
flow cytometry using antibodies targeting CD11c (clone N418) and MHCII (clone AF6.120.1)
using a FACSCalibur (BD). Analysis was performed using FlowJo software (Tree Star).
Statistics
Results are shown as mean ± SEM. One-way ANOVA or two-way Student’s T-tests were per-
formed by Graphpad Prism 6.0 to compare the means between the groups as indicated in
the figure legends. Differences with a P< 0.05 were considered significant; , P < 0.05;
, P < 0.01; , P < 0.001; , P < 0.0001.
Supporting information
S1 Table. Primers used for qPCR analysis.
(PDF)
S1 Movie. Typical example of lymphatic contractions in a Cx47+/+Prox1tg/+ mouse.
(MOV)
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